The program will begin in June with the ECHO member companies and their employees or dependents with diabetes. ALRT’s CHC and the Health ALRT Diabetes System is a comprehensive patient compliance system and communications software platform that will enable health care professionals to remotely monitor the health progress specifically relating to diabetic patients. This will help diabetics reap the full therapeutic benefits of their medication by encouraging adherence to blood sugar testing and medications. Moreover, the system will facilitate effective and “real time” communication of blood sugar and other data to health professionals. This will facilitate timely intervention by health professionals as required and control complications due to diabetes. The program will also provide diabetic supplies from Health ALRT, LLC, an innovative health services company located in Kennesaw, GA... ALR Technologies' Press Release -
Blog Archive
-
▼
2008
(233)
-
▼
May
(27)
- Pipex Pharmaceuticals : Oral Flupirtine Patent Est...
- Daiichi Sankyo : AZOR Reduces Blood Pressure in Di...
- DiaMedica : pre-IND FDA Guidance on DM-71
- ALR Technologies : ECHO of Alabama Employer Coalit...
- AtheroGenics : ARISE Trial Results Published in Th...
- Daiichi Sankyo : Welchol, Combined With Metformin ...
- DiaMedica : Enrollment in Phase II Clinical Trial ...
- Allon : potential of AL-309 as a new neuropathy tr...
- Entelos : Agreement with Lilly
- FivePrime and Pfizer : Diabetes Collaboration
- Diasome Pharmaceuticals : at the 68th Annual Ameri...
- Phenomix : PHX1149 Phase 2b Clinical Trial Results...
- Aradigm : Data Showing No Occurrence of Primary Lu...
- MicroIslet : Collaboration With DiaKine Intended T...
- CytRx : Discovery of Novel Compounds that Amplify ...
- RegeneRx : Ophthalmic Patent in Hong Kong
- Elixir Pharmaceuticals : Issuance of SIRT Patent C...
- OXiGENE : Active Metabolite of ZYBRESTAT Improves...
- Incyte : Positive Clinical Progress
- Merck's JANUMET (sitagliptin/metformin HCl) Recomm...
- Pfizer : Research Consortium to Expand Understandi...
- NOVAGALI : First Patient in U.S. Phase I Clinical ...
- Solianis Monitoring : Non-Invasive Glucose Monitoring
- Nektar Terminates All Negotiations With Potential ...
- CureDM : Diabetes Therapy Major Development Achieved
- Biocon Limited : Phase IIa Clinical Trials for IN105
- Toumaz Technology and Consortium Partners : Major ...
-
▼
May
(27)
Tuesday, May 27, 2008
ALR Technologies : ECHO of Alabama Employer Coalition To Conduct New Diabetes Program Using The ALR Technologies Constant Health Companion...
May 27, 2008 - ALR Technologies Inc. (OTCBB: ALRT) announces that ECHO, Employers Coalition for Healthcare Options for corporations in Alabama, will start a program using ALRT’s Constant Health Companion™ (“CHC”) and its complementary Health ALRT Diabetes Management System.